Month: December 2021

Suominen Corporation ANNOUNCEMENT 30.12.2021          Suominen Corporation: SHARE REPURCHASE 30.12.2021     In the Helsinki Stock Exchange         Trade date 30.12.2021  Bourse trade Buy  Share SUY1V  Amount 5,250 SharesAverage price/ share 5.1538 EURTotal cost 27,057.45 EUR          Suominen Corporation now holds a total of 965 984 sharesincluding the shares repurchased on 30.12.2021          On behalf of Suominen Corporation       Nordea Bank Oyj         Janne Sarvikivi Sami Huttunen       For additional information, please contact:  Toni Tamminen, CFO, Suominen Corporation  tel. +358 (0)10 214 3051         www.suominen.fi    AttachmentSuominen 30.12 trades

NEW YORK and LONDON, Dec. 30, 2021 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX) (“Akari” or the “Company”), a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where the complement and/or leukotriene systems are implicated, today announced that it has entered into definitive agreements with institutional investors and accredited investors, led by existing investors of the Company, including Dr. Ray Prudo, the Company’s Chairman, to receive gross proceeds of approximately $6.0 million. In connection with the offering, the Company will issue approximately 4,310,839 registered American Depository Shares (ADSs) of Akari at a purchase price of $1.40 per ADS in a registered direct offering. Additionally, for each ADS purchased by investors, the investors will...

Company announcement – No. 78 / 2021 Total number of shares and voting rights in Zealand Pharma at December 30, 2021 Copenhagen, DK and Boston, MA, December 30, 2021 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, in accordance with section 32 of the Danish Capital Markets Act, announces the total number of shares and voting rights in the Company at the end of a calendar month during which there have been changes to its share capital.   In Company announcement No. 74/2021 from December 10, 2021, Zealand announced an increase in share capital relating to the exercise of employee warrants. Following this announcement, the table below lists the total number of shares and voting rights in Zealand up...

New York, NY, Dec. 30, 2021 (GLOBE NEWSWIRE) — iQSTEL, Inc. (OTCQX: IQST) today released another letter to shareholders from the CEO, Leandro Iglesias, in an ongoing series of updates in conjunction with the company’s ongoing initiative to up-list on Nasdaq. The CEO’s latest letter to shareholders is included in its entirety below: Dear Shareholders: The new year is hours away and I could not be more pleased or proud of all iQSTEL’s accomplishments in 2021.  I will share today the latest updates and one particularly exciting milestone that will usher us promptly along our way to a Nasdaq listing in 2022. We have already announced that iQSTEL will exceed its $60.5 million 2021 revenue forecast.  Today, I’m happy to share that as of the writing of this letter, we have surpassed $64 million inching past our revised $63 million 2021...

Šiaulių Bankas AB has received notification on disposal of voting rights. Jolanta DobiliauskienėDirector of Securities Operations Department+370 41 595669, jolanta.dobiliauskienė@sb.ltAttachmentNotification on disposal of shares

MARKHAM, Ontario, Dec. 30, 2021 (GLOBE NEWSWIRE) — Sangoma Technologies Corporation (“Sangoma” or the “Company”) (TSX: STC, NASDAQ: SANG), a trusted leader in delivering cloud-based Communications-as-a-Service (“CaaS”) solutions, today announced that at the annual meeting of shareholders held yesterday (the “Meeting”), each of the five nominees listed in the management information circular dated November 25, 2021 were elected as directors of the Company. A total of 8,532,609 common shares or 44.8% of Sangoma’s issued and outstanding common shares as of the record date of November 24, 2021 were voted in connection with the Meeting. Shareholders voted by ballot in favour of each item of business. The detailed results of the vote in respect of the directors of the Company are set out below.Name of Nominee Votes cast FOR* % votes...

Copenhagen, Dec. 30, 2021 (GLOBE NEWSWIRE) — Announcement no. 20-2021 Inside InformationAfter evaluating pros and cons, it has been decided that Hypefactors will discontinue the collaboration with the liquidity provider Lago Kapital. This with effect from January 3rd, 2022.—– About Hypefactors A/S Hypefactors is an integrated AI powered Earned Media tech platform to support better media intelligence, reputation and trust management. Hypefactors combine data, analytics, technology and tools to provide a unified and easy-to-use experience. With all the tools to automate and ease the work, and all the facts to document the results. In addition to media monitoring across the different media channels, the platform provides access to a number of facts, incl. automated documentation of the monetary value and quality assessment...

Primary Mortgage Market Survey®U.S. weekly average mortgage rates as of December 30, 2021.MCLEAN, Va., Dec. 30, 2021 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today released the results of its Primary Mortgage Market Survey® (PMMS®), showing that the 30-year fixed-rate mortgage (FRM) averaged 3.11 percent. “Mortgage rates have effectively been moving sideways despite the increase in new COVID cases. This is because incoming economic data suggests that the economy remains on firm ground, particularly cyclical industries like manufacturing and housing. Moreover, low interest rates and high asset valuations continue to drive consumer spending,” said Sam Khater, Freddie Mac’s Chief Economist. “While we do expect rates to rise, the push of the first-time homebuyer demographic that’s been propelling the purchase market...

COVAXIN™ whole virus inactivated vaccine generated broad antibody response comparable to those seen in a large phase 3 trial in adults 18+ Adverse events were primarily mild, and no serious adverse events (SAEs) were noted Immunobridging trial demonstrated safety, reactogenicity and immunogenicity of COVAXIN™ in children from 2 years old and up No cases of myocarditis or blood clots were reported, as expected with inactivated vaccinesMALVERN, Pa., Dec. 30, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (Nasdaq: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics and vaccines, announced today that its partner, Bharat Biotech, posted results from a Phase 2/3 trial conducted in India of candidate vaccine, COVAXIN™ (BBV152), in children, aged 2 – 18 years, demonstrating a robust neutralizing...

GRAND RAPIDS, Mich., Dec. 30, 2021 (GLOBE NEWSWIRE) — Independent Bank Corporation (NASDAQ: IBCP), the holding company of Independent Bank, a Michigan-based community bank, announced that it expects to issue its 2021 fourth quarter results on Thursday, January 27, 2022, at approximately 8:00 am ET. The release will be available on the Internet at IndependentBank.com within the “News” section of the “Investor Relations” area of the Company’s website. Brad Kessel, President and CEO, Gavin Mohr, CFO and Joel Rahn, EVP Commercial Banking will review the quarterly results in a conference call for investors and analysts beginning at 11:00 am ET on Thursday, January 27, 2022. To participate in the live conference call, please dial 1-866-200-8394. Also the conference call will be accessible through an audio webcast with user-controlled...